Ikena Oncology, Inc. (IKNA) has disclosed a new risk, in the Employment / Personnel category.
Ikena Oncology, Inc. faces a significant business risk due to its workforce reduction strategy, which aims to decrease staff by approximately 53% by the end of September 2024. The company’s execution of strategic transactions hinges on the retention of key remaining employees, whose expertise is crucial for these initiatives. However, the cost-cutting measures may inadvertently lead to higher attrition and waning morale, prompting critical personnel to pursue opportunities elsewhere. Should Ikena fail to maintain its essential workforce, the company risks disruption in both strategic transaction efforts and overall business operations.
The average IKNA stock price target is $3.00, implying 73.41% upside potential.
To learn more about Ikena Oncology, Inc.’s risk factors, click here.
